TAXUS PERSEUS Workhorse

Completed · Phase 3

Conditions studied: Coronary Artery Disease

In brief

The purpose of the TAXUS PERSEUS Workhorse trial is to evaluate the safety and efficacy of the next-generation Boston Scientific TAXUS paclitaxel-eluting coronary stent system (TAXUS® ElementTM) for the treatment of de novo atherosclerotic lesions of up to 28 mm in length in native coronary arteries of 2.75 mm to 4.0 mm diameter.

Key facts

Study ID
NCT00484315
Run by
Boston Scientific Corporation
People needed
1264
Starts
2007-07-01
Expected to finish
2013-10-01
Last updated by the study team
2014-05-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.